Haemonetics Corp. (hae 2.5 06/01/29)
13F holders, Q3 2025 (September 30)7holders +1
2new positions
1sold out
$0.92avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Haemonetics Corp. (hae 2.5 06/01/29) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were New York State Common Retirement Fund ($3.7M), Income Research & Management ($2.9M) and State of Wisconsin Investment Board ($2.8M).
- Company
- Haemonetics Corp. (hae 2.5 06/01/29)
- CUSIP
- 405024AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2.8M |
| Exits | 1 | $1.9M |
All 13F filers, Q2 2025 → Q3 2025: 3,239,000 shares bought and 2,801,000 shares sold, net +438,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| New York State Common Retirement Fund | 0.00% | Reduce -17.8% | 4,013,000 | $3.7M |
| Income Research & Management | 1.43% | Add +5.4% | 3,145,000 | $2.9M |
| State of Wisconsin Investment Board | 0.01% | New | 3,000,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | No change | 500,000 | $461K |
| &partners | 0.00% | New | 79,000 | $73K |
| Cetera Investment Advisers | 0.00% | Reduce -11.4% | 31,000 | $29K |
| Choreo, LLC | 0.00% | No change | 28,000 | $26K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 2.5 06/01/29)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 2.5 06/01/29) the manager owns.